Atlas Trials

Prognostic Effect of Whether Doing PLND During RC for High-risk NMIBC

Clinical trial NCT05123625 · RECRUITING

Trial details

NCT number
NCT05123625
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2021-07-01
Primary completion
2027-06-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.